Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: A community-based long-term prospective study

Journal of Infectious Diseases

Volumn 206, Issue 4, 2012, Pages 469-477

  Lee, Mei Hsuan ^a   Yang, Hwai I ^a,b,c   Lu, Sheng Nan ^d   Jen, Chin Lan ^a   You, San Lin ^a   Wang, Li Yu ^e   Wang, Chih Hao ^f   Chen, Wei J ^g   Chen, Chien Jen ^a,g   Hsieh, C Y ^h   Lee, H S ^h   Yang, P M ^h   Chen, C H ^h   Chen, J D ^h   Huang, S P ^h   Jan, C F ^h   Chen, T H H ^g   Sun, C A ⁱ   Wu, M H ^j   Chen, S Y ^k   Chu, K E ^l   Ho, S C ^m   Lu, T G ^m   Wu, W P ⁿ   Ou, T Y ⁿ   Lin, C G ^o   Shih, K C ^p   Chung, W S ^q   Li, C ^q   Chen, C C ^r   How, W C ^s   more..

^a GENOMICS RESEARCH CENTER   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^e MACKAY MEDICAL COLLEGE   (Taiwan)

^f CARDINAL TIEN HOSPITAL   (Taiwan)

^g NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^h NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

ⁱ NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^j TAIPEI CITY PSYCHIATRIC CENTER   (Taiwan)

^k TZU CHI UNIVERSITY   (Taiwan)

^l SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^m Huhsi Health Center   (Taiwan)

ⁿ Department of Internal Medicine   (Taiwan)

^o Provincial Chutung Hospital   (Taiwan)

^p Provincial Potzu Hospital   (Taiwan)

^q Kaohsu Health Center   (Taiwan)

^r Kaohsu Health Center   (Taiwan)

^s Paihsa Health Center   (Taiwan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; VIRUS RNA;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; DEATH CERTIFICATE; ESOPHAGUS CANCER; FEMALE; HEPATITIS C; HUMAN; INFECTION RISK; ISCHEMIA; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEPHRITIS; NEPHROSIS; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; THYROID CANCER; BLOOD; LONGITUDINAL STUDY; MIDDLE AGED; RISK ASSESSMENT;

ADULT; AGED; FEMALE; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK ASSESSMENT; RNA, VIRAL;

EID: 84866898184     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis385     Document Type: Article

References (30)

1. Lauer GM, Walker BD. Hepatitis C virus infection.[see comment]. N Engl J Med 2001; 345:41-52.
2. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006; 118:3030-44.
3. Guiltinan AM, Kaidarova Z, Custer B, et al. Increased all-cause, liver, and cardiac mortality among hepatitis C virus-seropositive blood donors. Am J Epidemiol 2008; 167:743-50.
4. Seeff LB, Buskell-Bales Z, Wright EC, et al. Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group. N Engl J Med 1992; 327:1906-11.
5. Wiese M, Grungreiff K, Guthoff W, Lafrenz M, Oesen U, Porst H. Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany - a 25-year multicenter study. J Hepatol 2005; 43:590-8.
6. Ali A, Zein NN. Hepatitis C infection: a systemic disease with extrahepatic manifestations. Cleve Clin J Med 2005; 72:1005-8.
7. Blackard JT, Kemmer N, Sherman KE. Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. Hepatology 2006; 44:15-22.
8. Poynard T, McHutchison J, Manns M, et al. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology 2002; 122:1303-13.
9. Lee MH, Yang HI, Lu SN, et al. Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study. J Clin Oncol 2010; 28:4587-93.
10. Iloeje UH, Yang HI, Jen CL, et al. Risk and predictors of mortality associated with chronic hepatitis B infection. Clin Gastro Hepatol 2007; 5:921-31.
11. Chen CJ, Yang HI, Su J, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006; 295:65-73.
12. Fwu CW, Chien YC, Nelson KE, et al. Mortality after chronic hepatitis B virus infection: a linkage study involving 2 million parous women from Taiwan. J Infect Dis 2010; 201:1016-23.
13. Montella M, Pezzullo L, Crispo A, et al. Risk of thyroid cancer and high prevalence of hepatitis C virus. Oncol Rep 2003; 10:133-6.
14. Wise M, Bialek S, Finelli L, Bell BP, Sorvillo F. Changing trends in hepatitis C-related mortality in the United States, 1995-2004. Hepatology 2008; 47:1128-35.
15. Lehman EM, Wilson ML. Epidemic hepatitis C virus infection in Egypt: estimates of past incidence and future morbidity and mortality. J Viral Hepat 2009; 16:650-8.
16. Chowdhury A, Santra A, Chaudhuri S, et al. Hepatitis C virus infection in the general population: a community-based study in West Bengal, India. Hepatology 2003; 37:802-9.
17. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. [see comment]. N Engl J Med 1999; 341:556-62.
18. McMahon BJ, Hennessy TW, Christensen C, et al. Epidemiology and risk factors for hepatitis C in Alaska Natives. Hepatology 2004; 39:325-32.
19. Uto H, Stuver SO, Hayashi K, et al. Increased rate of death related to presence of viremia among hepatitis C virus antibody-positive subjects in a community-based cohort study. Hepatology 2009; 50:393-9.
20. Amin J, Law MG, Bartlett M, Kaldor JM, Dore GJ. Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community- based linkage study. Lancet 2006; 368:938-45.
21. Lee MH, Yang HI, Wang CH, et al. Hepatitis C virus infection and increased risk of cerebrovascular disease. Stroke 2010; 41:2894-900.
22. Hansson GK. Mechanisms of disease - inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352:1685-95.
23. Tsui JI, Vittinghoff E, Shlipak MG, et al. Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease. Arch Intern Med 2007; 167:1271-6.
24. Daghestani L, Pomeroy C. Renal manifestations of hepatitis C infection. Am J Med 1999; 106:347-54.
25. Giordano TP, Henderson L, Landgren O, et al. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA 2007; 297:2010-7.
26. Sun CA, Chen HC, Lu CF, et al. Transmission of hepatitis C virus in Taiwan: prevalence and risk factors based on a nationwide survey. J Med Virol 1999; 59:290-6.
27. Sun CA, Chen HC, Lu SN, et al. Persistent hyperendemicity of hepatitis C virus infection in Taiwan: the important role of iatrogenic risk factors. J Med Virol 2001; 65:30-4.
28. Lee MH, Yang HI, Jen CL, et al. Community and personal risk factors for hepatitis C virus infection: a survey of 23,820 residents in Taiwan in 1991-2. Gut 2011; 60:688-94.
29. Shin HR, Kim JY, Kim JI, et al. Hepatitis B and C virus prevalence in a rural area of South Korea: the role of acupuncture. Br J Cancer 2002; 87:314-18.
30. Wasley A, Alter MJ. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 2000; 20:1-16.